A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC‐Remove

Summary This study describes the use of a simple charcoal product (DOAC‐Remove TM ) to allow haemostasis assays on patients taking direct oral anticoagulants (DOAC). In the proposed algorithm, patients taking DOAC are screened using the dilute thrombin time (dTT) and anti‐Xa assay. If either are positive then DOAC‐Remove is utilised. In a validation, DOAC‐Remove did not interfere with coagulation testing in normal plasma or in patients on DOAC...